Centralised authorisation procedure 2016
The Danish share of assignments in the European pharmaceutical collaboration.
The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.
Status for 2016 up to and including 4th quarter
Denmark was assigned 7 human rapporteur/co-rapporteur cases and 6 veterinary rapporteur/co-rapporteur cases, which are respectively 3 % and 9 % of all assigned central procedure cases in 2016.
Figure 1. Amount of assigned rapporteur/corapporteur cases in the EU in 2016 up to and including 4th quarter
,
Table 1: Assigned human rapporteur/co-rapporteur cases|
Number of human procedures |
2015 |
2016 |
||
|
Cases with DK as Rap/CO-rap |
Total amount of cases |
Cases with DK as Rap/CO-rap |
Total amount of cases |
|
|
1st quarter |
2 |
65 |
0 |
56 |
|
2nd quarter |
1 |
69 |
3 |
83 |
|
3rd quarter |
2 |
64 |
3 |
51 |
|
4th quarter |
2,5 |
54 |
1 |
73 |
|
Total |
7,5 |
252 |
7 |
263 |
Figure 3. Share of veterinary rapporteur/corapporteur cases in the EU in 2016 up to and including 4th quarter
Table 2: Assigned veterinary rapporteur/co-rapporteur cases
|
Number of veterinary procedures |
2015 |
2016 |
||
|
Cases with DK as Rap/CO-rap |
Total amount of cases |
Cases with DK as Rap/CO-rap |
Total amount of cases |
|
|
1st quarter |
2 |
7 |
2 |
22 |
|
2nd quarter |
2 |
20 |
2 |
23 |
|
3rd quarter |
4 |
25 |
2 |
16 |
|
4th quarter |
1 |
14 |
0 |
4 |
|
Total |
9 |
66 |
6 |
65 |